Navigation Links
Zocor Side Effects Update: Bernstein Liebhard LLP Comments on New Study Linking Kidney Problems to High Doses of Zocor, Other Statins
Date:4/13/2013

New York, New York (PRWEB) April 13, 2013

Bernstein Liebhard LLP notes that a new study is raising additional concerns about possible Zocor side effects, specifically kidney damage. The study, which was published online on March 19 in the British Medical Journal, found that patients treated with higher doses of statins like Zocor were 34% more likely to be hospitalized for acute kidney injury during the first 120 days of treatment.*

“This study just adds to a growing body of evidence that indicates Zocor side effects, especially those associated with higher doses, can be extremely dangerous. We have heard from a number of Zocor patients who have allegedly experienced serious complications, including rhadbomyolysis, a devastating muscle disorder that can lead to kidney damage,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is currently offering free legal evaluations to victims of Zocor side effects.

The British Medical Journal study involved more than 2 million people aged 40 or over taking either high or low doses of the statins Crestor, Lipitor or Zocor. According to the study authors, risk for acute kidney injury remained elevated for two years after the start of treatment. Pre-existing kidney disease was not found to increase the risk for acute kidney problems independent of statin use.

Zocor Muscle Injury Side Effects
According to Bloomberg.com, Zocor, known generically as simvastatin, ranks as one of the world’s best-selling drugs.** However, the medication has been linked to a number of serious Zocor side effects, including muscle injury, myopathy and rhadbomyolysis. In March 2010, the U.S. Food and Drug Administration (FDA) advised that the higher 80 mg dose of Zocor could be associated with muscle injuries. At the time, the agency also cautioned that the risk of Zocor muscle injuries increases for patients who take the drug in conjunction with other blood pressure medications.***

On June 8, 2011, the FDA added new warnings to Zocor’s labeling, and advised physicians not to prescribe high doses of Zocor to new patients. According to the FDA, high-dose Zocor prescriptions should be limited to patients who have taken 80 mg doses of Zocor for more than a year and have not experienced side effects. The FDA has cautioned patients to contact their doctor if they experience muscle pain, tenderness or weakness, dark or red colored urine, or unexplained tiredness, as these could be signs of serious Zocor side effects.****

Individuals who experienced Zocor side effects, including muscle injury, myopathy, or rhadbomyolysis may be able to collect compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about filing a Zocor lawsuit, please visit Bernstein Liebhard LLP’s website. For additional information, contact a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.

*bloomberg.com/news/2011-06-08/cholesterol-drug-s-highest-dose-should-be-limited-fda-says.html
** bmj.com/content/346/bmj.f880
***fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm204882.htm
****fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258384.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/zocor-lawsuits/zocor-side-effects/prweb10630147.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mirena Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on New Mirena IUD Side Effects Study
2. Doctors not informed of harmful effects of medicines during sales visits
3. Drug Company Reps Dont Tell Docs Enough About Side Effects: Survey
4. Teen Boys With Enlarged Breasts Show Emotional Effects
5. Agios research demonstrates the effects of mutant IDH1 and IDH2 inhibitors in primary tumor models
6. Statin Side Effects Often Manageable: Study
7. New research on the effects of traumatic brain injury
8. Gut Bacteria May Be Key to Gastric Bypass Effects: Study
9. Pneumonia May Lead to Serious Aftereffects for Seniors
10. GW researcher studies the dangerous effects of cocaine on HIV patients
11. Hormone Pills in Menopause May Carry Gallstone Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... LINCOLN, R.I. (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much ... Sleep Foundation (NSF), going just 19 hours without sleep can compromise motor reaction time, which ... Awareness Week, and Amica Insurance is sharing the following tips from the NSF to help ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: ... , “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on ... and Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management Association (RBMA) ... 2017-2018. The annual board election process has been in place since the RBMA was ... C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology: